Kiora Pharmaceuticals (KPRX) Tax Rate (2024 - 2025)
Kiora Pharmaceuticals' (KPRX) quarterly Tax Rate came in at 9.32% in Q4 2025, up 10499.0% YoY from N/an in Q4 2024, and down 91.07% on a QoQ basis from 104.35% in Q3 2025.
Kiora Pharmaceuticals (KPRX) Tax Rate (2024 - 2025) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 2 years of Tax Rate data on file, last reported at 9.32% in Q4 2025.
- Quarterly Tax Rate rose 10499.0% year-over-year to 9.32% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 11.42% (up 3360.0% YoY) and the FY2025 annual result came in at 10.73%, down 2576.0% from the prior year.
- Tax Rate declined to 9.32% in Q4 2025, from 104.35% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 104.35% in Q3 2025 to a low of 95.67% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn | 34.12% |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -16.71% |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | - |
| 10 | Kiora Pharmaceuticals | 16.06 Mn | 16.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.32% |
| Dec 31, 2025 | 9.32% |
| Dec 31, 2025 | 9.32% |
| Sep 30, 2025 | 104.35% |
| Sep 30, 2025 | 104.35% |
| Sep 30, 2025 | 104.35% |
| Jun 30, 2025 | 4.95% |
| Jun 30, 2025 | 4.95% |
| Jun 30, 2025 | 4.95% |
| Mar 31, 2025 | -5.94% |
| Mar 31, 2025 | -5.94% |
| Mar 31, 2025 | -5.94% |
| Dec 31, 2024 | -95.67% |
| Dec 31, 2024 | -95.67% |
| Dec 31, 2024 | -95.67% |